Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Buy
54
VEEV Quote, Financials, Valuation and Earnings
Last price:
$239.38
Seasonality move
:
12.34%
Day range:
$231.15 - $238.37
52-week range:
$170.25 - $258.93
Dividend yield:
0%
P/E ratio:
54.68x
P/S ratio:
14.22x
P/B ratio:
6.59x
Volume:
1.2M
Avg. volume:
1.3M
1-year change:
2.14%
Market cap:
$38.4B
Revenue:
$2.7B
EPS (TTM):
$4.33
Analysts' Opinion
-
Consensus RatingVeeva Systems has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 10 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $266.49, Veeva Systems has an estimated upside of 12.55% from its current price of $236.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $201.00 representing 100% downside risk from its current price of $236.77.
Fair Value
-
According to the consensus of 24 analysts, Veeva Systems has 12.55% upside to fair value with a price target of $266.49 per share.
VEEV vs. S&P 500
-
Over the past 5 trading days, Veeva Systems has overperformed the S&P 500 by 0.65% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Veeva Systems does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Veeva Systems has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Veeva Systems reported revenues of $720.9M.
Earnings Growth
-
Veeva Systems has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Veeva Systems reported earnings per share of $1.18.
Enterprise value:
33.3B
EV / Invested capital:
5.71x
Price / LTM sales:
14.22x
EV / EBIT:
48.15x
EV / Revenue:
12.12x
PEG ratio (5yr expected):
1.59x
EV / Free cash flow:
30.54x
Price / Operating cash flow:
35.82x
Enterprise value / EBITDA:
45.55x
Gross Profit (TTM):
$2B
Return On Assets:
11.08%
Net Income Margin (TTM):
26%
Return On Equity:
13.71%
Return On Invested Capital:
13.71%
Operating Margin:
26.14%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $2.2B | $2.4B | $2.7B | $630.6M | $720.9M | |
| Gross Profit | $1.5B | $1.7B | $2B | $456.7M | $539.9M | |
| Operating Income | $459.1M | $429.3M | $691.4M | $135.3M | $188.4M | |
| EBITDA | $488.2M | $462M | $730.8M | $143.9M | $198.4M | |
| Diluted EPS | $3.01 | $3.22 | $4.33 | $0.90 | $1.18 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.3B | $3.1B | $4B | $5B | $6.3B | |
| Total Assets | $3B | $3.8B | $4.8B | $5.9B | $7.3B | |
| Current Liabilities | $716M | $840.8M | $1B | $1.2B | $1.4B | |
| Total Liabilities | $779.7M | $904.8M | $1.1B | $1.3B | $1.5B | |
| Total Equity | $2.3B | $2.9B | $3.7B | $4.6B | $5.8B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $780.5M | $911.3M | $1.1B | $57.8M | $69.5M | |
| Cash From Investing | -$1B | -$1.1B | -$700.1M | -$86.7M | -$15.7M | |
| Cash From Financing | -$19.4M | -$16.2M | $26.1M | -$10.5M | $20.8M | |
| Free Cash Flow | $780.5M | $911.3M | $1.1B | $57.8M | $69.5M | |
VEEV
Sector
Market Cap
$38.4B
$39.2M
Price % of 52-Week High
91.44%
45.99%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.81%
1-Year Price Total Return
2.14%
-38.63%
Beta (5-Year)
0.883
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$234.81
200-day SMA
Buy
Level
$210.94
Bollinger Bands (100)
Buy
Level
215.11 - 235.39
Chaikin Money Flow
Buy
Level
188.2M
20-day SMA
Buy
Level
$229.94
Relative Strength Index (RSI14)
Buy
Level
55.23
ADX Line
Buy
Level
21.84
Williams %R
Neutral
Level
-31.7902
50-day SMA
Buy
Level
$228.05
MACD (12, 26)
Buy
Level
2.31
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
114.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (17.2206)
Buy
CA Score
(Annual)
Level (1.5023)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-4.4191)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Stock Forecast FAQ
In the current month, VEEV has received 13 Buy ratings 10 Hold ratings, and 1 Sell ratings. The VEEV average analyst price target in the past 3 months is $266.49.
-
Where Will Veeva Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Veeva Systems share price will rise to $266.49 per share over the next 12 months.
-
What Do Analysts Say About Veeva Systems?
Analysts are divided on their view about Veeva Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Veeva Systems is a Sell and believe this share price will drop from its current level to $201.00.
-
What Is Veeva Systems's Price Target?
The price target for Veeva Systems over the next 1-year time period is forecast to be $266.49 according to 24 Wall Street analysts, 13 of them rate the stock a Buy, 1 rates the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is VEEV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Veeva Systems is a Buy. 13 of 24 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VEEV?
You can purchase shares of Veeva Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Veeva Systems shares.
-
What Is The Veeva Systems Share Price Today?
Veeva Systems was last trading at $239.38 per share. This represents the most recent stock quote for Veeva Systems. Yesterday, Veeva Systems closed at $236.77 per share.
-
How To Buy Veeva Systems Stock Online?
In order to purchase Veeva Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 24
Regencell Bioscience Holdings [RGC] is down 23.96% over the past day.
Buy
54
TNXP alert for Mar 24
Tonix Pharmaceuticals Holding [TNXP] is up 30.48% over the past day.
Sell
36
VMI alert for Mar 24
Valmont Industries [VMI] is up 3.93% over the past day.
